# Ferric Citrate for the Transition From CKD Stage 4/5 to CKD Stage 5D

> **NCT02492620** · PHASE3 · COMPLETED · sponsor: **Denver Nephrologists, P.C.** · enrollment: 200 (actual)

## Conditions studied

- Chronic Kidney Disease
- Hyperphosphatemia
- Iron Deficiency Anemia
- Renal Insufficiency

## Interventions

- **DRUG:** Ferric Citrate

## Key facts

- **NCT ID:** NCT02492620
- **Lead sponsor:** Denver Nephrologists, P.C.
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2017-11
- **Final completion:** 2017-11
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2018-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02492620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02492620, "Ferric Citrate for the Transition From CKD Stage 4/5 to CKD Stage 5D". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02492620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*